Italia markets closed

BMY Jun 2024 42.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,2500+0,2900 (+9,80%)
Alla chiusura: 12:24PM EDT
Schermo intero
Chiusura precedente2,9600
Aperto3,3900
Denaro3,4500
Lettera3,5500
Prezzo d'esercizio42,00
Scadenza2024-06-21
Min-Max giorno3,2500 - 3,3900
Contratto - Min-MaxN/D
Volume5
Open Interest123
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri